News & Investors

Want to stay updated? Subscribe to our newsletters. For free.

Have questions? Our live support would be happy to help you.

You are here: epigenomics > News & Investors

News & Investors

19. September 2022 - 0:00 (CEST)

Epigenomics AG: Raise of earnings guidance for the current fiscal year 2022 due to currency gains and lower study costs

Read more

19. September 2022 - 0:00 (CEST)

Epigenomics Initiates prospective multi-center clinical trial for “Next-Generation” blood-based colorectal cancer test

Read more

09. September 2022 - 0:00 (CEST)

Epigenomics AG: Capital reduction planned at a ratio of 4 : 1

Read more

15. August 2022 - 0:00 (CEST)

Epigenomics AG: Notice of Loss pursuant to Sec. 92 par. 1 AktG

Read more

10. August 2022 - 0:00 (CEST)

Epigenomics AG Reports Financial Results for the First Six Months of 2022

Read more

19. July 2022 - 0:00 (CEST)

Epigenomics AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Read more